Showing results (211-220 of 534) with videos related to
Sort By:
Pageof 54
NPJ Digital Medicine|December 9, 2021
Passive detection of COVID-19 with wearable sensors and explainable machine learning algorithmsMatteo Gadaleta, Jennifer M Radin, Katie Baca-Motes, et al.JAMA|October 23, 2003
Prognostic importance of physical examination for heart failure in non-ST-elevation acute coronary syndromes: the enduring value of Killip classificationUmesh N Khot, Gang Jia, David J Moliterno, et al.Circulation. Cardiovascular Interventions|December 25, 2009
Relationship between baseline inflammatory markers, antiplatelet therapy, and adverse cardiac events after percutaneous coronary intervention: an analysis from the clopidogrel for the reduction of events during observation trialKristofer Dosh, Peter B Berger, Steven Marso, et al.Journal of Cardiovascular Pharmacology and Therapeutics|December 31, 2005
Bivalirudin vs heparin in percutaneous coronary intervention: a pooled analysisRamin Ebrahimi, A Michael Lincoff, John A Bittl, et al.Circulation|April 1, 2003
Relation of inflammation and benefit of statins after percutaneous coronary interventionsAlbert W Chan, Deepak L Bhatt, Derek P Chew, et al.Circulation|June 18, 2003
Increased expression of thrombospondin-1 in vessel wall of diabetic Zucker ratOlga I Stenina, Irene Krukovets, Kai Wang, et al.Circulation|May 1, 2004
Thrombocytopenia caused by abciximab or tirofiban and its association with clinical outcome in patients undergoing coronary stentingPiera Angelica Merlini, Marco Rossi, Alberto Menozzi, et al.The American Journal of Cardiology|April 13, 2002
Evidence that angiotensin-converting enzyme inhibitor use diminishes the need for coronary revascularization after stentingStephen G Ellis, A Michael Lincoff, Patrick L Whitlow, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 28, 2002
Reduction in vascular access site bleeding in sequential abciximab coronary intervention trialsJames C Blankenship, Craig Balog, Shelly K Sapp, et al.Journal of the American College of Cardiology|September 3, 2002
Mortality benefit of beta-blockade after successful elective percutaneous coronary interventionAlbert W Chan, Martin J Quinn, Deepak L Bhatt, et al.Pageof 54